Non-st-elevation Myocardial Infarction

• FDA approval · 2022-06-14
  FDA Approved: ENOXAPARIN SODIUM — Original Application (BluePoint Laboratories)

  The FDA approved BluePoint Laboratories' original ANDA for enoxaparin sodium, a low molecular weight heparin, expanding availability of its …

• FDA approval · 2015-07-07
  FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for EFFIENT (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc.

• FDA approval · 2014-06-23
  FDA Approved: ENOXAPARIN SODIUM — Original Application (Italfarmaco SpA)

  FDA approved the original application for ENOXAPARIN SODIUM (enoxaparin sodium) submitted by Italfarmaco SpA under an ANDA. The approval con…